These innovative treatments, Retatrutide, represent a remarkable advancement in treating metabolic dysfunction and possibly related conditions . They are categorized as GLP-1 pathway agonists , meaning they function to mimic the body's GLP-1 hormone , boosting insulin secretion and lowering food